Citrulline Di-Malate (2:1).
Citrulline bonded to malic acid for double benefit Nitric oxide boost. Blood flow. Pumps. Endurance. Same benefits as regular citrulline malate.
Reviewed March 2026
- Category
- Amino acid
- Also filed under
- EndurancePumpsRecovery
What Citrulline Di-Malate (2:1) is, and what it does.
- Does it work
- Research is on citrulline and citrulline malate 2:1. This form less studied specifically but works.
- How much to take
- Start with 4,000 to 8,000mg a day of the 2 to 1 powder. Two thirds of that weight is citrulline, so 6,000mg gives you about 4,000mg of citrulline itself.
- Time to feel it
- Thirty to sixty minutes before a session is when the blood flow effect lands. Changes in training endurance accumulate over a few weeks of steady use.
- The first dose
- Plasma arginine climbs across the first hour, so a serving before training lands with that session. Nothing has to accumulate across days first.
- With regular use
- Weeks of steady use show up as better tolerance for high-repetition work and steadier session quality. The malate half keeps feeding the citric acid cycle throughout.
- How well tolerated
- Well tolerated. Mild GI upset possible at high doses. Nothing serious.
- How it feels
- Pumps. Endurance. Less burn during high-rep sets. Noticeable if you train hard.
- The overlooked benefit
- The ratio does the work: two parts citrulline to one part malic acid, so a scoop weighs more than the citrulline in it. Batch testing of that ratio keeps a label honest.
3,000 to 6,000mg a day is where Citrulline Di-Malate (2:1) works.
Source: Perez-Guisado 2010 + Bailey 2015 exercise study
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Repetitions completed in high-volume resistance setsRandomised trial
- Muscle blood flow during trainingRandomised trial
- Muscle soreness in the days after trainingRandomised trial
- Exercise performance measures overallMeta-analysis
- Plasma arginine availability from oral citrullineNarrative review
Questions people ask about Citrulline Di-Malate (2:1).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Should I take it on an empty stomach?
- Most amino acids absorb better on an empty stomach since they don't compete with food proteins for absorption. 30 minutes before meals is ideal.
- Can I get enough from protein?
- If you eat enough protein (0.8-1g per pound bodyweight), you probably get enough aminos. Supplementing specific ones only makes sense for targeted goals.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
The citrulline portion is converted to arginine by argininosuccinate synthase and lyase after bypassing intestinal arginase. Substrate and supply route in one pairing.
Ornithine forms citrulline in the mitochondrion and is regenerated when arginine is cleaved by arginase. Both intermediates support normal ammonia handling.
A two-to-one malate ratio already delivers a large malate load as a citric acid cycle intermediate, and this salt adds more. Stacking them is not neutral, so the combined malate should be counted.
Ascorbate maintains tetrahydrobiopterin in its reduced form so nitric oxide synthase stays coupled to arginine. It governs how efficiently the arginine formed from citrulline is spent.
Nitrate reduction produces nitric oxide without needing an enzyme substrate or oxygen, unlike the arginine route citrulline feeds. The two routes complement each other.
Beta-alanine raises carnosine for pH buffering while the citrulline half supports nitric oxide and ammonia clearance. Different limits on repeated effort.
Creatine works on phosphate transfer and cell hydration, citrulline di-malate on blood flow and cycle carbon. Neither pathway substitutes for the other.
Glutathione limits oxidative loss of nitric oxide and supports its transport as nitrosothiols. Production capacity and signal survival are two different things.
Small intestinal cells convert glutamine to citrulline, which enters the circulation and is taken up by the kidney for conversion to arginine. Supplemental citrulline enters that circuit downstream of the gut step. The pathway is textbook; combining the two is a way of feeding it at two points rather than a measured additive effect.
Nitric oxide synthase needs tetrahydrobiopterin to produce nitric oxide from arginine; when the cofactor is scarce the enzyme uncouples and generates superoxide instead. 5-methyltetrahydrofolate is described as helping maintain the reduced cofactor pool. Citrulline supplies substrate to that enzyme, so cofactor status is the other half of the equation. The folate-biopterin link is mechanistic and less settled than the substrate side.
Bicarbonate raises extracellular buffering capacity while citrulline malate is used for perfusion and ammonia handling during repeated efforts. The two act on non-overlapping constraints, which is why they appear in the same pre-workout protocols. No combination trial is cited here, so the additive framing is design logic.
Citrulline feeds the nitric oxide pathway that relaxes vascular smooth muscle, while caffeine has a mild pressor and vasoconstrictive component through adenosine antagonism. Products routinely combine them for separate reasons, ergogenic and perfusion. The net vascular effect is not simply the sum, and it is a modulating rather than additive relationship.
Pycnogenol is studied for endothelial function measures and citrulline supplies the substrate arm of the same pathway. Combining a substrate with an agent acting on the enzyme side is a coherent formulation rationale. It rests on separate literatures rather than a trial of the pair.
Garlic organosulfur compounds are described in relation to nitric oxide signalling and vascular tone, and citrulline provides the arginine precursor. The overlap is at the pathway level. No combination measurement is offered here.
Taurine has roles in osmoregulation and calcium handling in muscle, distinct from nitric oxide substrate supply. The combination is a formulation convention in the category. It is not grounded in a study of the two together.
The two do different jobs in the same session, one supplying building material and the other addressing the vascular and nitrogen-handling side of the workout. Combining them is standard practice in the category. No interaction between them is claimed.
Malate is a citric acid cycle intermediate whose oxidation by malate dehydrogenase feeds NADH into the respiratory chain, where coenzyme Q10 carries electrons between complexes. The connection is at the level of shared mitochondrial machinery. It describes where the malate goes, not a demonstrated benefit of taking the two together.
Sodium supports plasma volume and fluid retention during sweat losses, while citrulline acts on vessel tone through the nitric oxide pathway. Both feed into blood delivery to working muscle from different directions. This is mechanistic reasoning rather than a measured combination.
Nothing specific on file for Citrulline Di-Malate (2:1). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Citrulline Di-Malate (2:1) actually does.
Citrulline escapes the intestinal and hepatic arginase activity that degrades much of an oral arginine dose, which is why oral citrulline raises plasma arginine more efficiently than an equivalent dose of arginine itself.
Citrulline is converted to arginine in the kidney by argininosuccinate synthase and argininosuccinate lyase, using aspartate and ATP.
Arginine is the substrate for nitric oxide synthase, which produces nitric oxide and regenerates citrulline, closing the citrulline-nitric oxide cycle.
Citrulline is an intermediate of the urea cycle, the pathway that converts ammonia into urea for excretion.
Where Citrulline Di-Malate (2:1) comes from.
The citrulline is usually made by growing bacteria on a sugar feedstock, though an enzyme-based conversion route is also used. Either way the citrulline is filtered out and purified into crystals. Those crystals are blended with malic acid, a sour compound found in apples, at two parts citrulline to one part malic acid. A lab test confirms the ratio, since that ratio is what the label is really promising.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
L-citrulline is typically produced by microbial fermentation of a carbohydrate feedstock such as glucose from corn or cane, using bacterial strains selected for arginine-pathway output.
Strains accumulate citrulline through the arginine biosynthetic pathway, or arginine is converted enzymatically to citrulline; the result is the L-enantiomer only, which is the form the kidney enzymes accept.
Cells and solids are removed from the fermentation broth by filtration or centrifugation, leaving the amino acid in solution.
Citrulline is captured on ion-exchange resin, eluted, concentrated and crystallised, then washed to remove residual broth components.
Crystalline L-citrulline is combined with malic acid in a controlled two-to-one weight ratio and co-processed to a uniform powder; the malic acid is itself made synthetically by hydration of maleic or fumaric acid, or obtained by fermentation.
Batches are assayed for citrulline content and the citrulline-to-malate ratio, since the ratio is the whole identity of the ingredient, along with optical rotation, moisture and heavy metals.
The combined material is milled and screened for solubility in a drink mix, then packed under moisture control because the malate component is hygroscopic.
Getting Citrulline Di-Malate (2:1) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Taking 6 to 8 g of citrulline malate 40 to 60 minutes before strength training increased repetitions performed before muscular failure by about 6% versus placebo, a small effect.Meta-analysis. Varvik et al., 2021 (Int J Sport Nutr Exerc Metab). PMID 34010809 ↗
- Citrulline supplementation, most commonly 8 g of citrulline malate before exercise, lowered post-exercise rating of perceived exertion and reduced muscle soreness at 24 hours, with no significant change in blood lactate.Meta-analysis. Rhim et al., 2020 (J Sport Health Sci). PMID 33308806 ↗
- Pooling 8 trials, oral L-citrulline supplementation lowered systolic blood pressure by about 4.1 mmHg, with a diastolic reduction seen only at doses of 6 g per day or more.Meta-analysis. Barkhidarian et al., 2019 (Avicenna J Phytomed). PMID 30788274 ↗
- Across 30 randomised trials and 644 participants, citrulline malate was linked to a small overall gain in exercise performance (g = 0.16, p = 0.01) with wide prediction intervals, no clear effect on perceived exertion, and GRADE certainty rated low to very low.Meta-analysis. Wang et al., 2026 (Nutrients). PMID 42356270 ↗
- Pooling four trials and 138 paired assessments in resistance-trained adults, citrulline malate did not measurably increase muscle strength (SMD 0.13, 95% CI -0.21 to 0.46), with similar results for upper and lower limbs.Meta-analysis. Aguiar and Casonatto, 2022 (Journal of Dietary Supplements). PMID 34176406 ↗
- Across eight randomised trials in 176 middle-aged and older adults, L-citrulline (not the malate form specifically) improved flow-mediated dilation, a marker of blood vessel widening, by 1.81 percentage points (95% CI 0.76 to 2.85), while whole-body pulse wave velocity showed no clear change.Meta-analysis. Luo et al., 2025 (Frontiers in Nutrition). PMID 41323997 ↗
- In a pilot trial, six weeks of citrulline malate alongside multicomponent training improved sit-to-stand time in physically active older women by about 1.6 seconds (p = 0.023), with non-significant trends in walking distance and physical performance battery score.Randomised trial. Ramos-Hernandez et al., 2026 (Clinical Nutrition ESPEN). PMID 42162613 ↗
- A systematic review with dose-response pooling of citrulline or watermelon supplementation trials reporting body composition measures across the included studies; body composition is the measured variable and the analysis is limited by the size and design of the pooled trials.Meta-analysis. Ashtary-Larky et al., 2025 (Nutrients). PMID 41097202 ↗
- Chronic supplementation combining nitrate with citrulline malate was assessed on performance and recovery variables across a competitive period.Randomised trial. Ramirez-Munera et al., 2025 (Nutrients). PMID 40733006 ↗
- Acute citrulline malate supplementation was tested in a randomised double-blind design on high-intensity functional fitness workout performance measures.Randomised trial. Devrim-Lanpir et al., 2024 (Nutrients). PMID 39408204 ↗
- Three days of citrulline malate supplementation was assessed on repeated short-duration sprint running performance.Randomised trial. Faria et al., 2024 (European Journal of Sport Science). PMID 38874989 ↗
- Acute citrulline malate supplementation increased total work performed in short lower-body isokinetic tasks compared with the control condition.Randomised trial. Gills et al., 2023 (Journal of Strength and Conditioning Research). PMID 34319940 ↗
- Citrulline malate supplementation was examined for its effect on muscle fatigue measures during a controlled fatiguing protocol.Randomised trial. Farney et al., 2019 (Journal of Strength and Conditioning Research). PMID 29176388 ↗
- The trial did not detect an effect of acute citrulline malate supplementation on aerobic cycling performance or on subsequent anaerobic performance; a failure to detect a difference in this protocol, not a demonstration that no effect exists.Randomised trial. Gills et al., 2021 (European Journal of Sport Science). PMID 31994989 ↗
- Acute citrulline malate supplementation was tested on repeated 100 metre sprint performance in a randomised design.Randomised trial. Yamanaka et al., 2026 (Sports). PMID 42043075 ↗
- Acute citrulline malate supplementation was assessed for nocturnal blood pressure dipping after exercise; blood pressure dipping is a haemodynamic marker rather than a clinical outcome.Randomised trial. Domingues et al., 2024 (Journal of Dietary Supplements). PMID 39385595 ↗
- A mechanism-focused overview of citrulline malate supplementation set against different high-intensity interval training protocols, mapping the nitric oxide and ammonia handling rationale against the reported performance measures.Narrative review. Nobari et al., 2025 (Heliyon). PMID 40040998 ↗
- A published correction to the mechanism overview above; it amends the record of that review rather than adding new data.Narrative review. Nobari et al., 2025 (Heliyon). PMID 41395033 ↗
These are the studies our verdict leans on, chosen from the 79 we read for Citrulline Di-Malate (2:1). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.